title: [Current position of the Professional Group of Dermatologic Oncology on high dosage therapy with interferon-alpha-2b].
authors.affiliation: Klinik für Dermatologie und Allergologie der Ruhr-Universität Bochum.
authors.forename: N H
authors.initials: NH
authors.lastname: Brockmeyer
authors.forename: K
authors.initials: K
authors.lastname: Hoffmann
authors.forename: P
authors.initials: P
authors.lastname: Altmeyer
mesh_terms: D004305:Dose-Response Relationship, Drug; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage* / Q000009:adverse effects; D008545:Melanoma / Q000188:drug therapy* / Q000401:mortality; D011446:Prospective Studies; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000401:mortality; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins
vernacular_title: Aktuelle Stellungnahme der Arbeitsgemeinschaft Dermatologische Onkologie zur Hochdosistherapie mit Interferon-alpha-2b.